Veronica Veschi | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Neuroblastoma epigenetic landscape: drugging opportunities	Neuroblastoma discoveries and challenges	2024
Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression	STAR Protocol	2024
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells	NATURE COMMUNICATIONS	2023
Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment	FRONTIERS IN MOLECULAR MEDICINE	2023
A single-cell transcriptomic analysis of Neuroblastomas revealed a selective cGAS-STING pathway suppression in malignant cells	PROCEEDINGS IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE	2023
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy	JOURNAL OF CLINICAL MEDICINE	2022
Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy	BIOMOLECULES	2022
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51	ONCOGENE	2022
Cancer cell targeting by CAR-T cells: A matter of stemness	FRONTIERS IN MOLECULAR MEDICINE	2022
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells	CANCERS	2022
Targeting epigenetic alterations in cancer stem cells	FRONTIERS IN MOLECULAR MEDICINE	2022
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy	CANCERS	2021
Cancer stem cell biomarkers predictive of radiotherapy response in rectal cancer: A systematic review	GENES	2021
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment	FRONTIERS IN ONCOLOGY	2021
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery	NATURE COMMUNICATIONS	2021
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin	ISCIENCE	2021
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells	GUT	2021
Targeting MYCN in Pediatric and Adult Cancers	FRONTIERS IN ONCOLOGY	2021
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant	ONCOGENE	2020
The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer	CELL STEM CELL	2020